87 related articles for article (PubMed ID: 20175052)
1. Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy.
Blouza S; Dakhli S; Abid H; Aissaoui M; Ardhaoui I; Ben Abdallah N; Ben Brahim S; Ben Ghorbel I; Ben Salem N; Beji S; Chamakhi S; Derbel A; Derouiche F; Djait F; Doghri T; Fourti Y; Gharbi F; Jellouli K; Jellazi N; Kamoun K; Khedher A; Letaief A; Limam R; Mekaouer A; Miledi R; Nagati K; Naouar M; Sellem S; Tarzi H; Turki S; Zidi B; Achour A;
J Nephrol; 2010; 23(4):415-24. PubMed ID: 20175052
[TBL] [Abstract][Full Text] [Related]
2. One year course of oral sulodexide in the management of diabetic nephropathy.
Achour A; Kacem M; Dibej K; Skhiri H; Bouraoui S; El May M
J Nephrol; 2005; 18(5):568-74. PubMed ID: 16299683
[TBL] [Abstract][Full Text] [Related]
3. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
Lambers Heerspink HJ; Fowler MJ; Volgi J; Reutens AT; Klein I; Herskovits TA; Packham DK; Fraser IR; Schwartz SL; Abaterusso C; Lewis J;
Diabet Med; 2007 Nov; 24(11):1290-5. PubMed ID: 17956455
[TBL] [Abstract][Full Text] [Related]
4. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
5. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
[TBL] [Abstract][Full Text] [Related]
6. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
8. Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.
Heerspink HL; Greene T; Lewis JB; Raz I; Rohde RD; Hunsicker LG; Schwartz SL; Aronoff S; Katz MA; Eisner GM; Mersey JH; Wiegmann TB;
Nephrol Dial Transplant; 2008 Jun; 23(6):1946-54. PubMed ID: 18089623
[TBL] [Abstract][Full Text] [Related]
9. [The efficacy of Sulodexide--a low-molecular heparin--in the therapy of diabetic nephropathy].
Shestakova MV; Chugunova LA; Vorontsov AV; Dedov II
Ter Arkh; 1997; 69(6):34-7. PubMed ID: 9297270
[TBL] [Abstract][Full Text] [Related]
10. Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.
Gambaro G; Kinalska I; Oksa A; Pont'uch P; Hertlová M; Olsovsky J; Manitius J; Fedele D; Czekalski S; Perusicová J; Skrha J; Taton J; Grzeszczak W; Crepaldi G
J Am Soc Nephrol; 2002 Jun; 13(6):1615-25. PubMed ID: 12039991
[TBL] [Abstract][Full Text] [Related]
11. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
[TBL] [Abstract][Full Text] [Related]
12. [A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
Zalevskaia AG; Astamirova KhS; Karpova IA; Popova SG
Ter Arkh; 1998; 70(3):71-4. PubMed ID: 9575594
[TBL] [Abstract][Full Text] [Related]
13. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients.
Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A
Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814
[TBL] [Abstract][Full Text] [Related]
14. Losartan in diabetic nephropathy.
Perico N; Ruggenenti P; Remuzzi G
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
[TBL] [Abstract][Full Text] [Related]
15. Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
Skrha J; Perusicová J; Pont'uch P; Oksa A
Diabetes Res Clin Pract; 1997 Oct; 38(1):25-31. PubMed ID: 9347243
[TBL] [Abstract][Full Text] [Related]
16. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
17. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
[TBL] [Abstract][Full Text] [Related]
18. Thailand diabetes registry project: prevalence, characteristics and treatment of patients with diabetic nephropathy.
Ngarmukos C; Bunnag P; Kosachunhanun N; Krittiyawong S; Leelawatana R; Prathipanawatr T; Plengvidhya N; Benjasuratwong Y; Suwanwalaikorn S; Deerochanawong C; Chetthakul T; Mongkolsomlit S; Rawdaree P
J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S37-42. PubMed ID: 17715832
[TBL] [Abstract][Full Text] [Related]
19. Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy.
Tamsma JT; van der Woude FJ; Lemkes HH
Nephrol Dial Transplant; 1996 Jan; 11(1):182-5. PubMed ID: 8649631
[TBL] [Abstract][Full Text] [Related]
20. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]